Doctor of Philosophy, University of Toledo, 2017, Chemistry
Canavan disease is a progressive, fatal neurological disorder that is caused by defects in the human ASPA gene, which leads to an interruption in the metabolism of N-acetylaspartic acid (NAA). NAA is the second most abundant amino acid in the human brain. It is synthesized by aspartate N-acetyltransferase in neuronal mitochondria and is hydrolyzed by aspartoacylase in oligodendrocytes. Multiple therapies are currently under investigation to identify a treatment for Canavan disease.
Aspartoacylase has previously been successfully expressed, kinetically characterized, and structurally characterized. To provide further insights about this enzyme, a series of mass spectrometry-based protein analysis studies have been performed. The amino acid sequence of aspartoacylase was confirmed by high-performance liquid chromatography/matrix-assisted laser desorption/ionization (MALDI) tandem mass spectrometry. No post-translational modifications, in particular asparagine-linked glycosylation that were previously implicated, were identified.
Aspartate N-acetyltransferase (ANAT) has been shown to be a membrane associated enzyme with a putative membrane region of about 30 amino acid residues. While detergent extraction and several protein engineering approaches in the putative membrane domain failed to produce a soluble and active form of the enzyme, a tandem affinity purification approach using maltose-binding protein as fusion tag was able to produce an active and soluble enzyme form suitable for inhibitor development. Aspartate N-acetyltransferase was found to have high substrate specificity. Only three compounds, ß-methylaspartate, 2,3-diaminosuccinate, and L-glutamate, were identified as alternative substrates from 160 different amino acid analogs that were examined. Several factors that could affect ANAT activity were also tested. Triton X-100 and Tween 20 were identified to have the least impact on ANAT activity after a screening of a detergent library. The effect of v (open full item for complete abstract)
Committee: Ronald Viola (Committee Chair); Donald Ronning (Committee Member); Dragan Isailovic (Committee Member); Robert Blumenthal (Committee Member)
Subjects: Analytical Chemistry; Biochemistry; Chemistry